Sofinnova Investments, Inc. Karuna Therapeutics, Inc. Transaction History

Sofinnova Investments, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$176.32 - $240.22 $69.1 Million - $94.2 Million	-391,975 Reduced 22.11%	1,381,149 $300 Million
Q1 2023 May 11, 2023	SELL	$161.33 - $204.36 $48.4 Million - $61.3 Million	-300,000 Reduced 14.47%	1,773,124 $322 Million
Q2 2022 Aug 15, 2022	BUY	$93.97 - $143.33 $11.3 Million - $17.2 Million	120,047 Added 6.15%	2,073,124 $262 Million
Q3 2021 Nov 15, 2021	BUY	$101.2 - $125.87 $64,363 - $80,053	636 Added 0.03%	1,953,077 $239 Million
Q3 2020 Nov 13, 2020	BUY	$71.31 - $109.74 $4.77 Million - $7.33 Million	66,839 Added 3.54%	1,952,441 $151 Million

Q4 2019 Feb 14, 2020	BUY	$11.44 - $123.99 $1.79 Million - $19.4 Million	156,250 Added 9.04%	1,885,602 $142 Million
Q2 2019 Aug 13, 2019	BUY	$20.02 - $20.02 $34.6 Million - $34.6 Million	1,729,352 New	1,729,352 $34.6 Million

333K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Sofinnova Investments, Inc. with notifications on news.